MedPath

Effect of Hypocalcemia on the Outcome of Elderly Major Trauma Patients With Trauma-induced Coagulopathy

Conditions
Trauma
Coagulopathy
Interventions
Other: hypocalcemia
Registration Number
NCT05530161
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

Hypocalcaemia is an independent risk factor of TIC in elderly trauma patients. TIC combined with hypocalcemia had worse coagulation function and more serious acidosis.

Detailed Description

This 5-year retrospective, observational, single-center study was conducted at the Second Affiliated Hospital of Zhejiang University Medical School (SAHZU, China). Elderly patients with trauma were registered when they were admitted into intensive care unit affiliated to department of Emergency medicine (EICU) since January 2015 and September 2020.The purpose of this study is to elucidate the effect of hypocalcemia on TIC in elderly trauma patients through a single-center retrospective study, so as to further optimize the diagnosis and treatment strategies for TIC in elderly trauma patients.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
371
Inclusion Criteria
  • age≥65 years old
  • history of trauma
Exclusion Criteria
  • previous anticoagulants or antiplatelet medication;
  • Coagulopathy caused by previous underlying diseases;
  • Blood products transfused before admission;
  • Cardiac arrest on admission;
  • Malignant tumor;
  • Data incomplete

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
trauma induced coagulopathyhypocalcemiapatients with INR\>1.2
Primary Outcome Measures
NameTimeMethod
Internationalized Normalized Ratio (INR)24 hour

coagulation function :Internationalized Normalized Ratio (INR)

Activated Partial Thromboplastin Time (APTT)24 hour

coagulation function : Activated Partial Thromboplastin Time (APTT)

Prothrombin Time (PT)24 hour

coagulation function : Prothrombin Time (PT)

Secondary Outcome Measures
NameTimeMethod
Blood products ratethrough study completion, an average of 1 week

the rate of Blood products use

Trial Locations

Locations (1)

SAHZU

🇨🇳

Hanzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath